Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

Oct. 8th, 2012; Eli Lilly made this important

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Lil' Jon Member Profile
 
Followed By 60
Posts 2,983
Boards Moderated 0
Alias Born 01/21/10
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 4:16:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 4:11:56 PM
PDL BioPharma Reports 2019 Third Quarter Financial Results PR Newswire (US) - 11/6/2019 4:05:00 PM
PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019 PR Newswire (US) - 10/30/2019 9:00:00 AM
PDL BioPharma Responds to Letter from Engine Capital PR Newswire (US) - 10/24/2019 10:06:00 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/23/2019 8:57:33 AM
Engine Capital Issues Open Letter to Board of PDL BioPharma PR Newswire (US) - 10/23/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2019 7:06:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:01:36 AM
PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference PR Newswire (US) - 9/26/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 5:09:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 6:01:39 AM
PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024 PR Newswire (US) - 9/12/2019 10:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 6:02:29 AM
PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation PR Newswire (US) - 9/11/2019 10:44:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/29/2019 4:43:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2019 4:34:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:32:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:24:02 PM
Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/5/2019 4:10:00 PM
PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019 PR Newswire (US) - 7/31/2019 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2019 5:03:37 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/28/2019 6:01:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:25:31 PM
PDL BioPharma Announces Departure of CFO PR Newswire (US) - 6/25/2019 4:05:00 PM
Lil' Jon   Monday, 10/15/12 06:48:13 PM
Re: None
Post # of 206 
Oct. 8th, 2012; Eli Lilly made this important announcement on the Alzheimer medication Solanezumab, of which, if successful, PDL BioPharma will receive royalties from.

Mr. Funtleyder makes that assertion near the end of this video on Bloomberg.

http://us.rd.yahoo.com/finance/external/bloomberg/SIG=1335p4e22/*http://www.bloomberg.com/video/funtleyder-on-lilly-s-alzheimer-s-drug-nWW6TV~eTdmCZYnGfrGxjg.html?cmpid=yhoo
__________________________________________________________

"An experimental Alzheimer's treatment from Eli Lilly & Co. slowed memory loss by 42% in patients with a mild form of the memory-robbing disease in one drug trial and showed positive signs of doing so in another study, according to new data presented on Monday.

The results, although mixed, bolster hopes that a drug like Lilly's solanezumab could stymie Alzheimer's destructive march in patients in the early stage of the disease. Current therapies do nothing more than treat the symptoms. Yet more studies probably will be needed to reach a firm conclusion.

"Our next step is to talk to the regulators to see what this means, although we think this is a step forward in getting to a treatment for Alzheimer's," David Ricks, president of Lilly Bio-Medicines, said in an interview.

http://online.wsj.com/article/SB10000872396390444897304578044520966644406.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist